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Transverse myelitis (TM) is a focal inflammatory demyelinating disorder of the spinal cord. It commonly occurs due to an autoimmune process and the prevalence of 
the condition ranges from 1 to 8 cases/million per year [1]. TM is 
usually characterized by focal magnetic resonance imaging (MRI) 
signal abnormality in the spinal cord and/or cerebrospinal fluid 
(CSF) pleocytosis. Although the involvement is never transverse, 
the term has been retained due to the importance of a sensory level 
in the spinal segment, an essential element in the diagnosis [2].
TM is commonly divided on the basis of the extent of spinal 
involvement, i.e., acute complete TM (ACTM) and acute partial 
TM (APTM). ACTM classically presents with moderate-to-
severe loss of function distal to spinal level in comparison 
to APTM, which is characterized by incomplete to patchy 
involvement of at least one spinal segment with mild-to-moderate 
weakness, asymmetric, or dissociated sensory symptoms [1]. 
Lesion extending >3 spinal segments in length is diagnosed as 
longitudinally extensive TM (LETM). LETM has been associated 
with various vaccines such as hepatitis B, measles mumps rubella 
(MMR), rabies, oral polio vaccine, and influenza but rarely 
associated with post-DPT vaccination [3,4]. Here, we present 
the case of extensive involvement of the cervical segment in a 
21-month-old child and confirmed the diagnosis of a severe form 
of DPT vaccine-induced LETM.
CASE REPORT
A 21-month-old female toddler referred from dependent hospital 
to our center with a history of loss of the control of neck of 
1-day duration. There was no history of difficulty in swallowing, 
breathing, or difficulty in passing urine or stool or history of altered 
sensorium. There was no history of fall, trauma, or antecedent 
history suggestive of gastroenteritis or upper respiratory tract 
infection. There was a history of booster DPTw vaccination 
27 days before presentation to the dependent hospital.
On general examination, the child was found to have non-
significant cervical lymphadenopathy, pallor, and full neck flop. 
On central nervous system (CNS) examination, the child was 
conscious with Glasgow Coma Scale of 15/15 and hypotonia in the 
neck muscles. The power as per muscle research council (MRC) 
was 3/5 for neck flexors and 2/5 for neck extensors. Limb powers 
in both the upper and lower limbs were normal at all the joints. 
Reflexes were normal in the lower limbs, however, were poorly 
elicitable in both the upper limbs. Plantar was flexor bilaterally 
and other superficial reflexes were normal. There were no signs 
of cerebellar involvement or any signs of meningeal irritation. 
There was no evidence of sensory or autonomic involvement. Her 
fundus examination and other systemic examinations were also 
normal.
On laboratory investigation, the child had aspartate 
aminotransferase 364 IU/dl and alanine aminotransferase 
569 IU/dl which normalized after 6 days of admission. Her CSF 
examination showed no cells, normal sugar (53 mg with a blood 
sugar of 92 mg/dl), and protein of 22 mg/dl with an absence of 
the oligoclonal band. CSF culture for bacteria and fungus was 
negative. Her initial MRI done after 2 days of illness in the 
referring hospital was normal; however, repeat MRI done on the 
6th day of presentation for spine and brain showed T2 hyperintense 
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signal in cord parenchyma from C2 to C6. Rest of the spine 
and brain parenchyma revealed no significant demyelinating 
changes. MRI images demonstrated LETM (Fig. 1). The child 
was investigated for the presence of tuberculosis, Epstein–Barr 
virus, enterovirus in a polymerase chain reaction, and anti-
aquaporin 4 antibodies in CSF and all the investigations were 
found negative. Her serum anti-aquaporin 4 antibody, antinuclear 
antibody, cytoplasmic antineutrophil cytoplasmic antibodies, and 
perinuclear antineutrophil cytoplasmic antibodies for vasculitis 
and workup for human immunodeficiency virus, mycoplasma, 
and Epstein–Barr virus were also negative. Her Vitamin B12 
level was 216 pg/ml (normal 200–600 pg/ml). All the above-
mentioned clinical and laboratory investigations confirmed the 
final diagnosis DPT vaccine-induced extensive LETM.
In view of LETM, the child was started on immune modulation 
with intravenous immunoglobulin (IvIG) in doses of 2 g/per kg 
over 2 days. The child had shown only some clinical improvement 
in next 72 h; hence, a 5-day pulse of methylprednisolone at 
30 mg/kg/day was given intravenously followed by oral prednisolone 
of 1 mg/kg/day. From the 4th day of methylprednisolone pulse, the 
child started showing improvement, and by the 7th day of starting 
pulse steroid, the child recovered full range of neck movement and 
normal power at all groups of neck muscles. Visual evoked potential 
done at the time of discharge was normal. The child was discharged 
after 14 days of admission with advice to continue prednisolone for 
2 weeks followed by tapering over 3 weeks and monthly follow-up 
in the OPD. A follow-up spine MRI done at 3 months showed non-
enhancing altered signal intensity in the cervical spinal segment 
from C2 to C5 (T2 sagittal) (Fig. 2).
DISCUSSION
TM is a focal inflammatory demyelinating disorder of the spinal 
cord. LETM involves >3 spinal segments in length. Occasionally, 
it involves entire length of the spinal cord which entails a severe 
form of LETM [5]. At present, a bimodal distribution is observed 
in children under 5 years and older than 10 years of age [4,6].
Ever since vaccination is being used to control infectious 
disease, the pitfalls and side effects of vaccines known as 
adverse effect following immunization are being reported. 
Several most common complications related to neurological 
systems are documented in literature such as TM, Guillain-
Barre syndrome, neuromyelitis optica, and acute demyelinating 
encephalomyelitis [6]. The diagnosis in the case is based on 
excluding other causes and with epidemiological evidence. 
TMCWG (TM consortium working group) has proposed criteria 
for the diagnosis of TM which requires exclusion of idiopathic 
TM, bilateral signs and symptoms (though not necessarily 
symmetric), and exclusion of extra-axial compressive etiology 
by neuroimaging [7]. This case fits in these criteria and also had 
MRI evidence of LETM in the cervical segment C2–C6. Since 
it is difficult to pinpoint the exact causal relationship with the 
vaccine, a hypothesis has been proposed for the possibility of TM 
following vaccination. Only few cases have been published in 
literature due to post-DPT vaccination till date [8]. Other vaccines 
which have been implicated in TM are MMR, H1N1, and Hepatitis 
B vaccination. It is a vaccine adjuvant which has been specifically 
considered triggering agent for vaccine-associated TM [8,9].
Autoimmunity theory has been proposed which is due cross-
reactivity of antibodies and T-cells to the peripheral nervous 
system or CNS [10]. The other hypothesis which has been 
proposed is “Molecular mimicry” which portends those similar 
proteins of microbial pathogens with human proteins result in 
an immune response that damages the human organ system [11]. 
Diagnosis is based on clinical features and confirmed by MRI of 
the spine. Cervicothoracic segment or thoracic segment is usually 
the most common area of involvement.
The treatment is essentially immune modulation by steroid or 
IvIG (Class IV) or by plasmapheresis. There is no randomized trial 
in children published in literature to prove the superiority of one 
over other; however, a STRIVE trial protocol has been published 
in 2015 and results are pending; therefore, the choice of drug is 
dependent on individual preferences, cost, and availability [12]. 
Plasmapheresis has been recently recommended by the American 
Academy of Neurology for a subgroup of patients who fail to 
respond to high-dose corticosteroid treatment. This procedure 
Figure 1: Sagittal images of spine demonstrating high signal intensity 
from C2 to C6 in T2W
Figure 2: Sagittal images of cervical spine demonstrating high signal 
intensity - arrow from C2 to C5 in T2W at 12-week follow-up
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is technically difficult and hence is not routinely done in the 
children. For relapsed cases or NMO related, Cyclophosphamide, 
Rituximab or Ecluzimab have been tried occasionally. Prognosis 
in TM is generally good in children; however, LETM lesions 
with extensive involvement of ≥7 spinal segments showed poor 
functional recovery in at 3-month follow-up [12]. In another 
study of 19 patients with TM, rapid progression of symptoms, 
high level of deficit, and spinal shock were associated with poorer 
outcome [13]. In a study from North India in Pediatric TM, spinal 
shock, severe weakness at onset with power ≤1/5 on MRC scale, 
respiratory muscle involvement, and greater mean time to diagnosis 
and treatment had poorer outcome during follow-up [14].
CONCLUSION
TM is an acute/subacute inflammatory disorder of the spinal cord 
and may be due to a cross-reaction from vaccines. This diagnosis 
is only by excluding other causes and with epidemiological 
correlation. The early diagnosis and early treatment with immune 
therapy yields satisfactory results.
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